Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Carbetocin on QT/QTc Interval in Healthy Subjects
NCT05924321Phase 1Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (3 arms), sponsored by Ferring Pharmaceuticals. Primary endpoints: Observed Heart rate, Change from baseline of HR and 1 more. Started May 2023; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05924321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05924321.